Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon (Q50654674)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 1999

Language	Label	Description	Also known as
English	Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon	scientific article published in December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

secondary progressive multiple sclerosis

0 references

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

Gareth J. Barker

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

author name string

D H Miller

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

P D Molyneux

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

D G MacManus

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

I F Moseley

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

K Wagner

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

46

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

850-859

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

A review of some statistical methods for covariance analysis of categorical data

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Oligodendrocyte injury is an early event in lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

21 January 2018

Identifiers

10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/10589537

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50654674&oldid=1221860751"